Personalized antifungal dosing for older adults with fungal infections
Part of Infections clinical trials.
This study looks at how to best personalize the dose of the antifungal drug isavuconazole for older adults (60+) with serious fungal infections. By measuring drug levels in the blood, doctors hope to make treatment safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years of age or older.
- You have a serious fungal infection, such as invasive aspergillosis or mucormycosis.
- You are receiving or about to receive the antifungal medicine isavuconazole, and treatment is expected to last at least 48 hours.
- You are able to have blood samples taken safely.
- You are not allergic to isavuconazole.
- You are not pregnant, breastfeeding, or planning to become pregnant soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study monitors how the antifungal drug isavuconazole works in children's bodies. It aims to find the right dose for treating serious fungal infections.
This study tests a medicine called isavuconazole, which is used to treat serious fungal infections. It aims to see if it is safe and works well in very sick patients in the intensive care unit (ICU).
This trial tests whether using a genetic test to set the first dose of voriconazole (an antifungal medicine) can make treatment safer and more effective for people with blood cancers. It aims to reduce side effects and improve how well the drug works.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
This trial tests if using genetic information can help doctors choose the right dose of the antifungal drug voriconazole. It aims to improve treatment and reduce side effects for people with fungal infections.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
Hear when a new Isavuconazole trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.